| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Richard G. Wunderink | Q38323212 |
| P2093 | author name string | Kathryn A Radigan | |
| P2860 | cites work | SARS: systematic review of treatment effects | Q21144696 |
| Immunoglobulin treatment for respiratory syncytial virus infection | Q24243780 | ||
| Glucocorticoids for acute viral bronchiolitis in infants and young children | Q24246721 | ||
| The role of viruses in nosocomial pneumonia | Q37831038 | ||
| Evaluation of a multiplex reverse transcriptase PCR ELISA for the detection of nine respiratory tract pathogens. | Q37867192 | ||
| A cluster of cases of severe acute respiratory syndrome in Hong Kong. | Q37869740 | ||
| Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review | Q37988801 | ||
| Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management | Q39516717 | ||
| Analysis of antigenic drift in recently isolated influenza A (H1N1) viruses using monoclonal antibody preparations | Q39556498 | ||
| Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin | Q39866426 | ||
| Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV. | Q39926740 | ||
| Rapid diagnosis of human parainfluenza virus type 1 infection by quantitative reverse transcription-PCR-enzyme hybridization assay. | Q40011280 | ||
| The Seattle Virus Watch. VII. Observations of adenovirus infections | Q40062353 | ||
| Comparison of nasopharyngeal aspirate and nasopharyngeal swab specimens for respiratory syncytial virus diagnosis by cell culture, indirect immunofluorescence assay, and enzyme-linked immunosorbent assay. | Q40190445 | ||
| Varicella | Q40278402 | ||
| Detection of human bocavirus in hospitalised children | Q40397417 | ||
| Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients | Q40484554 | ||
| A 1-year experience with human metapneumovirus in children aged <5 years | Q40536374 | ||
| Serology of severe acute respiratory syndrome: implications for surveillance and outcome | Q40537884 | ||
| Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study | Q40543264 | ||
| Development of real-time PCR assays for detection and quantification of human bocavirus. | Q54539659 | ||
| Live attenuated versus inactivated influenza vaccine in infants and young children. | Q55043222 | ||
| Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome | Q57016763 | ||
| Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus | Q57203441 | ||
| Emerging Infections: Adenovirus Infections in Transplant Recipients | Q58066880 | ||
| Factors Predicting Mortality in Necrotizing Community-Acquired Pneumonia Caused by Staphylococcus aureus Containing Panton-Valentine Leukocidin | Q58441900 | ||
| Severe Acute Respiratory Syndrome | Q59187114 | ||
| Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir | Q62200249 | ||
| Increasing incidence of adenovirus disease in bone marrow transplant recipients | Q64383568 | ||
| Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response | Q68569796 | ||
| Acute respiratory illness in an American community. The Tecumseh study | Q68672836 | ||
| Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients | Q69351607 | ||
| Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients | Q69832474 | ||
| Parainfluenza infections in the elderly 1976-82 | Q70174346 | ||
| Adenovirus pneumonia in lung transplant recipients | Q71739556 | ||
| The clinical features of the pneumonias undergoing virus tests | Q75936131 | ||
| Corticosteroids in life-threatening varicella pneumonia | Q77194166 | ||
| Bacterial pneumonia. Managing a deadly complication of influenza in older adults with comorbid disease | Q77781485 | ||
| Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibody | Q79795066 | ||
| Evidence of human bocavirus circulating in children and adults, Cleveland, Ohio | Q82012430 | ||
| Viral and Host Strategies to Take Advantage of the Innate Immune Response | Q82034252 | ||
| Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection | Q24538772 | ||
| Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo | Q24567591 | ||
| Severe pneumonia and human bocavirus in adult | Q24628860 | ||
| Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis | Q24644585 | ||
| Racemic epinephrine compared to salbutamol in hospitalized young children with bronchiolitis; a randomized controlled clinical trial [ISRCTN46561076]. | Q24810199 | ||
| Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action | Q27867721 | ||
| Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials | Q28178690 | ||
| Two fatal cases of adenovirus-related illness in previously healthy young adults--Illinois, 2000 | Q28206715 | ||
| Viral pneumonia in the first month of life | Q28243713 | ||
| Viral community-acquired pneumonia in nonimmunocompromised adults | Q28256002 | ||
| Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009 | Q28260987 | ||
| Understanding the symptoms of the common cold and influenza | Q28279275 | ||
| Guillain-Barré syndrome after exposure to influenza virus | Q28291850 | ||
| Decline in mortality due to varicella after implementation of varicella vaccination in the United States | Q28305665 | ||
| Clinical and Molecular Pathogenesis of Varicella Virus Infection | Q28315797 | ||
| Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 | ||
| A novel coronavirus associated with severe acute respiratory syndrome | Q29617553 | ||
| Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection. | Q30304110 | ||
| Clinical virology of rhinoviruses | Q30304428 | ||
| Influenza virus neuraminidase inhibitors | Q30305461 | ||
| Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages | Q30307040 | ||
| Viral infections in immunocompromised patients: what's new with respiratory viruses? | Q30309653 | ||
| Role of hemagglutinin cleavage for the pathogenicity of influenza virus. | Q30322358 | ||
| Insights into the interaction between influenza virus and pneumococcus | Q30355570 | ||
| Antiviral management of seasonal and pandemic influenza. | Q30358735 | ||
| Patients hospitalized with 2009 pandemic influenza A (H1N1) - New York City, May 2009. | Q30384175 | ||
| Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons | Q30387439 | ||
| Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States | Q30388312 | ||
| Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza | Q30389887 | ||
| Clinical aspects and cytokine response in severe H1N1 influenza A virus infection | Q30396035 | ||
| Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). | Q30400038 | ||
| Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores | Q30401605 | ||
| Influenza--a model of an emerging virus disease | Q30422420 | ||
| Pandemic swine influenza virus (H1N1): A threatening evolution | Q30422869 | ||
| Severe acute respiratory syndrome: radiographic and CT findings | Q35159256 | ||
| Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS) | Q35536083 | ||
| Pharmacologic treatment of bronchiolitis in infants and children: a systematic review | Q35646375 | ||
| Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children | Q35697523 | ||
| Pulmonary complications of solid organ and hematopoietic stem cell transplantation | Q35740698 | ||
| Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China | Q35880772 | ||
| SARS-CoV infection in a restaurant from palm civet | Q36009490 | ||
| Treatment and vaccines for severe acute respiratory syndrome | Q36070672 | ||
| Cytomegalovirus pneumonia in transplant recipients | Q36303294 | ||
| Viral pneumonias other than cytomegalovirus in transplant recipients | Q36303297 | ||
| A role for immune complexes in enhanced respiratory syncytial virus disease | Q36371267 | ||
| Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. | Q36534733 | ||
| Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients. | Q36542986 | ||
| Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association | Q36602721 | ||
| Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. | Q36707840 | ||
| Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group | Q36754280 | ||
| Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease | Q36784740 | ||
| Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient | Q36829670 | ||
| Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients | Q36936492 | ||
| Respiratory viral infections in transplant recipients | Q36974612 | ||
| Infection in solid-organ transplant recipients | Q37038203 | ||
| Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada | Q37055208 | ||
| Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice | Q37241332 | ||
| Clinical practice. Prevention and treatment of seasonal influenza | Q37346639 | ||
| Community-acquired pneumonia: the U.S. perspective | Q37417657 | ||
| Role of viral infections, atopy and antiviral immunity in the etiology of wheezing exacerbations among children and young adults | Q30439055 | ||
| Recovery of drug-resistant influenza virus from immunocompromised patients: a case series | Q30439558 | ||
| Symptom profile of common colds in school-aged children | Q30445313 | ||
| Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. | Q30471016 | ||
| Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data | Q31054765 | ||
| Varicella among adults: data from an active surveillance project, 1995-2005. | Q31152922 | ||
| Varicella pneumonia | Q33451047 | ||
| Chickenpox pneumonia: an association with pregnancy | Q33604149 | ||
| Viruses and bacteria in the etiology of the common cold | Q33657199 | ||
| Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit | Q33676173 | ||
| The global impact of influenza on morbidity and mortality | Q33725066 | ||
| A newly discovered human pneumovirus isolated from young children with respiratory tract disease | Q33845279 | ||
| Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients | Q33877782 | ||
| A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo | Q33936520 | ||
| Respiratory syncytial virus and parainfluenza virus | Q33952428 | ||
| Respiratory syncytial virus infection in adults | Q33961877 | ||
| Recent advances in the treatment of rhinovirus infections | Q34107038 | ||
| Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 | Q34129986 | ||
| Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. | Q34143550 | ||
| The common cold | Q34169126 | ||
| Risk of primary infection and reinfection with respiratory syncytial virus | Q34188122 | ||
| Population-based studies of varicella complications | Q34189875 | ||
| Role of free radicals in viral pathogenesis and mutation | Q34191797 | ||
| Spread of adenovirus to geographically dispersed military installations, May-October 2007. | Q34194128 | ||
| Varicella pneumonia in adults | Q34199642 | ||
| Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong | Q34202150 | ||
| Guillain-Barré syndrome following influenza vaccination | Q34370829 | ||
| Neuraminidase inhibitors for influenza | Q34455162 | ||
| Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience. | Q34645847 | ||
| NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention | Q34681071 | ||
| A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections | Q34698361 | ||
| Viral pneumonias in adults: radiologic and pathologic findings | Q34959183 | ||
| Parainfluenza virus infection in adult lung transplant recipients: an emergent clinical syndrome with implications on allograft function | Q35072098 | ||
| The impact of adenovirus infection on the immunocompromised host | Q35125131 | ||
| Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study | Q40557821 | ||
| Treatment of severe acute respiratory syndrome with convalescent plasma | Q40557957 | ||
| Identification of severe acute respiratory syndrome in Canada | Q40562241 | ||
| Respiratory syncytial virus infections in previously healthy working adults | Q40597674 | ||
| Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro | Q40630466 | ||
| Varicella-zoster virus pneumonitis | Q40666111 | ||
| The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation | Q40782966 | ||
| Quantitative shedding patterns of respiratory syncytial virus in infants | Q42150565 | ||
| Rapid and quantitative detection of human adenovirus DNA by real‐time PCR | Q42597301 | ||
| Factors associated with early hospital discharge of adult influenza patients. | Q43176079 | ||
| Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial | Q43618923 | ||
| Incidence and characteristics of viral community-acquired pneumonia in adults. | Q43708189 | ||
| Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia | Q43717505 | ||
| Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. | Q44383245 | ||
| Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. | Q44546357 | ||
| Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybrid | Q44656414 | ||
| Apnea associated with respiratory syncytial virus infection in young infants | Q44797439 | ||
| Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation | Q44917627 | ||
| Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin | Q44923546 | ||
| Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia | Q44937806 | ||
| Resistant influenza A viruses in children treated with oseltamivir: descriptive study | Q45036693 | ||
| The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients | Q45134213 | ||
| A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection | Q45148150 | ||
| From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections | Q45381657 | ||
| Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. | Q45384083 | ||
| Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. | Q45384495 | ||
| Nodular lung calcifications following varicella zoster virus pneumonia | Q45397989 | ||
| Evaluation of the efficacy of prednisolone in early wheezing induced by rhinovirus or respiratory syncytial virus | Q45416167 | ||
| Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation | Q45421427 | ||
| Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis | Q45695798 | ||
| Detection of herpes simplex virus type 1, herpes simplex virus type 2 and varicella-zoster virus in skin lesions. Comparison of real-time PCR, nested PCR and virus isolation | Q45696581 | ||
| Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. | Q45729513 | ||
| Respiratory syncytial virus infection of the lower respiratory tract: radiological findings in 108 children | Q45734560 | ||
| Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome | Q45736390 | ||
| Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. | Q45739727 | ||
| Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial | Q45747450 | ||
| The host response, not the virus, causes the symptoms of the common cold | Q45756513 | ||
| Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients | Q45766275 | ||
| Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. | Q45779057 | ||
| Can respiratory syncytial virus and influenza A be distinguished clinically in institutionalized older persons? | Q45784353 | ||
| A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection | Q45854326 | ||
| Adamantane resistance in influenza A. | Q46956251 | ||
| Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units | Q47820521 | ||
| Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America | Q48585293 | ||
| Adenovirus infections and respiratory illnesses in children in group day care. | Q50560465 | ||
| Adenovirus infections in adult recipients of blood and marrow transplants. | Q50586082 | ||
| Paramyxovirus infection in lung transplant recipients | Q50589149 | ||
| Adenovirus infections in patients undergoing bone-marrow transplantation. | Q51198003 | ||
| Chest radiographic manifestations of severe acute respiratory syndrome in health care workers: the Toronto experience. | Q51638084 | ||
| Human metapneumovirus infections in young and elderly adults. | Q51685002 | ||
| Respiratory viruses and chronic rejection in lung transplant recipients. | Q51718915 | ||
| Venovenous perfusion of adults and children with severe acute respiratory distress syndrome. The Pennsylvania State University experience from 1982-1987. | Q51766429 | ||
| Development of a RT real-time PCR for the detection and quantification of human rhinoviruses. | Q54490701 | ||
| A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults. | Q54534754 | ||
| P433 | issue | 3 | |
| P921 | main subject | pneumonia | Q12192 |
| viral pneumonia | Q2603200 | ||
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | 451-467 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | Clinics in Chest Medicine | Q15754921 |
| P1476 | title | Epidemic viral pneumonia and other emerging pathogens | |
| P478 | volume | 32 |
Search more.